Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Dr. Brinda Emu Provides Insight into HIV Monoclonal Antibody Ibalizumab

OCT 19, 2017 | CONTAGION® EDITORIAL STAFF


Brinda Emu, MD, of the Infectious Diseases department at Yale University, offers insight into monoclonal antibody ibalizumab. Dr. Emu explains that the antiretroviral binds CD4—the primary receptor for HIV—and inhibits the viral entry process. Ibalizumab is active against all major HIV clades.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x